| Literature DB >> 28835478 |
Richard J N Allcock1,2, Amy V Jennison3, David Warrilow4.
Abstract
The standard paradigm for microbiological testing is dependent on the presentation of a patient to a clinician. Tests are then requested based on differential diagnoses using the patient's symptoms as a guide. The era of high-throughput genomic methods has the potential to replace this model for the first time with what could be referred to as "hypothesis-free testing." This approach utilizes one of a variety of methodologies to obtain a sequence from potentially any nucleic acid in a clinical sample, without prior knowledge of its content. We discuss the advantages of such an approach and the challenges in making this a reality. © Crown copyright 2017.Entities:
Keywords: bacteriology; bioinformatics; diagnostics; genome analysis; high-throughput sequencing; hypothesis-free testing; next-generation sequencing; personalized medicine; virology
Mesh:
Year: 2017 PMID: 28835478 PMCID: PMC5654900 DOI: 10.1128/JCM.01155-17
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948